Cite
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
MLA
Motomi Mori, et al. “Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.” Cell Reports, vol. 19, no. 1, Dec. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a08817ee336020446522259ee3f12be3&authtype=sso&custid=ns315887.
APA
Motomi Mori, Takahiro Tsujikawa, Molly Kulesz-Martin, Lei Zheng, Eric R. Lutz, Paul W. Flint, Daniel R. Clayburgh, Patrick Leyshock, Vahid Azimi, Adam A. Margolin, Rie Kawashima, Young Hwan Chang, Elizabeth M. Jaffee, Gina Choe, Joe W. Gray, Ariel Balter, Guillaume Thibault, Sushil Kumar, David Sauer, … Lisa M. Coussens. (2016). Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. Cell Reports, 19(1).
Chicago
Motomi Mori, Takahiro Tsujikawa, Molly Kulesz-Martin, Lei Zheng, Eric R. Lutz, Paul W. Flint, Daniel R. Clayburgh, et al. 2016. “Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.” Cell Reports 19 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a08817ee336020446522259ee3f12be3&authtype=sso&custid=ns315887.